You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天瑞儀器(300165.SZ):擬以7616萬元處置資產
格隆匯 05-19 20:23

格隆匯5月19日丨天瑞儀器(300165.SZ)公佈,公司、福建分公司以及子公司廈門質譜儀器儀表有限公司(“廈門質譜”)擬以人民幣7616萬元將公司和福建分公司從事的“基質輔助激光解吸電離飛行時間質譜儀(MALDI-TOF)”業務、人員及相關的資產(包括但不限於設備在內的所有有形資產以及專利、計算機軟件著作權等在內的所有無形資產)以及廈門質譜擁有的“基質輔助激光解吸電離飛行時間質譜儀(MALDI-TOF)”相關的全部資產(包括但不限於設備在內的所有有形資產以及計算機軟件著作權等在內的所有無形資產)整體轉讓給重慶拓譜生物工程有限公司。雙方已於2020年5月18日簽署了附生效條件的出售資產協議書。

基質輔助激光解吸電離飛行時間質譜儀(MALDI-TOF)僅是公司“大健康”發展戰略的一部分,公司將其出售有利於更好地配置公司資源、提高資產運營效率。公司雖不能繼續研發、生產基質輔助激光解吸電離飛行時間質譜儀(MALDI-TOF),但可以繼續銷售。

經公司財務部門初步測算,該項交易本身預計獲得的損益為3475.47萬元人民幣,對公司財務狀況產生積極影響。此次出售資產所得款項將用於補充公司和子公司流動資金。

重慶拓譜生物工程有限公司為重慶中元匯吉生物技術有限公司的全資子公司,為重慶元乾實業集團有限公司的控股孫公司。重慶元乾實業集團有限公司持有重慶中元匯吉生物技術有限公司51.46%的股權。重慶拓譜生物工程有限公司為此次交易特別設立的有限公司。為保證收購方具備此次收購的履約能力,重慶元乾實業集團有限公司作出了不可撤銷的承諾,承諾由其向重慶拓譜生物工程有限公司提供此次收購的所需全部資金,以保證此次交易的順利進行。如重慶拓譜生物工程有限公司無法履行收購義務的,由其承擔相應收購義務並支付相應對價。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account